Today, QUALIblood, a leading innovator in blood diagnostics and healthcare solutions, proudly announces the appointment of Julie Winand as the company’s new Chief Executive Officer (CEO), effective March 28, 2024. Simultaneously, Professor Jonathan Douxfils, founder and previously serving as CEO, transitions to the role of Chief Scientific Officer (CSO) and Chairman of the Board.
Full Press Release is available here 👇
